ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
-0.01%
Bitcoin
67,612.29
0.19%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Shattuck Labs Inc (STTK)

  7. Shattuck Labs Inc (STTK) News

STTK

Shattuck Labs (STTK)

Shattuck Labs Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STTK
DateTimeSourceHeadlineSymbolCompany
05/14/20243:15PMGlobeNewswire Inc.Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the EuNASDAQ:STTKShattuck Labs Inc
05/14/20243:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
05/02/20246:05AMGlobeNewswire Inc.Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
04/09/20243:05PMGlobeNewswire Inc.Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:STTKShattuck Labs Inc
04/01/20246:00AMGlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:STTKShattuck Labs Inc
03/08/20244:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
03/08/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
03/08/20244:29PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
03/06/20243:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STTKShattuck Labs Inc
03/04/20246:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
03/04/20246:00AMGlobeNewswire Inc.Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of DirectorsNASDAQ:STTKShattuck Labs Inc
02/29/20243:41PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:STTKShattuck Labs Inc
02/29/20243:23PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:STTKShattuck Labs Inc
02/29/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
02/29/20243:05PMGlobeNewswire Inc.Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
02/26/20246:00AMGlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming March ConferencesNASDAQ:STTKShattuck Labs Inc
02/14/20244:06AMPR Newswire (US)Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion ProteinsNASDAQ:STTKShattuck Labs Inc
02/13/20245:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
02/13/20245:00AMGlobeNewswire Inc.Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory DiseasesNASDAQ:STTKShattuck Labs Inc
02/02/20243:32PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:STTKShattuck Labs Inc
01/31/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:STTKShattuck Labs Inc
01/31/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/31/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/31/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/24/20243:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:STTKShattuck Labs Inc
01/16/20243:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/16/20243:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/16/20243:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/16/20243:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/10/20243:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STTKShattuck Labs Inc
 Showing the most relevant articles for your search:NASDAQ:STTK

Your Recent History

BIT
S31818
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved